KRYSTEN MILLETT: Open Payments
NPI 1235996109 · AUGUSTA, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$355 in 9 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $60 · 2025 $355
Food & beverage: $355
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 1 | $134 |
| AstraZeneca Pharmaceuticals LP | 3 | $103 |
| Genmab U.S., Inc. | 1 | $31 |
| Genentech USA, Inc. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Pharmacosmos Therapeutics Inc. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: Padcev, TAGRISSO, LYNPARZA, Tivdak, Itovebi, Fabhalta, MONOFERRIC, OPDIVO.
Industry payments across ME — which companies pay providers there.
